Shanghai Kinetic Medical Co., Ltd (SHE:300326)
China flag China · Delayed Price · Currency is CNY
6.48
+0.03 (0.47%)
Nov 13, 2026, 3:04 PM CST

Shanghai Kinetic Medical Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
734.04963.06984.52956.261,1661,269
Revenue Growth
-28.19%-2.18%2.96%-17.99%-8.08%19.50%
Gross Profit
450.51475.9479.09490.17740.07778.06
Operating Income
108.159.9379.1279.78212.26280.36
Net Income
268.88134.89-105.57112.54-21.28161.78
Earnings Per Share
0.370.19-0.150.16-0.030.22
EPS Growth
------

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Medical Device Manufacturing
612.65559.41564.07850.89869.88
Medical Device Trading
100.11142.59155.63140.37194.9
Device Disinfection Service Industry
233.27260.74213.93155.01192.75
Unallocated Other Operations
17.0421.7822.6319.7711.06
Total
963.06984.52956.261,1661,269

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
1,6831,5171,2191,042971.89906.83
Total Debt
50.3454.22326.48196.83328.49425.62
Net Cash (Debt)
1,6321,462892.06844.84643.41481.21
Net Cash Growth
63.63%63.93%5.59%31.31%33.71%-10.92%
Net Cash Per Share
2.282.041.241.180.890.67

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
230.44189.09157.75274.26236.76378.16
Capital Expenditures
-21.75-66.2-82.84-53.79-41.45-49.21
Free Cash Flow
208.69122.8874.91220.47195.3328.94
Free Cash Flow Growth
112.28%64.04%-66.02%12.89%-40.63%28.84%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
61.37%49.41%48.66%51.26%63.47%61.33%
Operating Margin
14.73%6.22%8.04%8.34%18.20%22.10%
Pretax Margin
36.92%15.11%-11.21%13.97%-0.19%17.05%
Profit Margin
36.63%14.01%-10.72%11.77%-1.82%12.75%
FCF Margin
28.43%12.76%7.61%23.06%16.75%25.93%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.1000.100-0.060-0.050
Dividend Per Share Growth
0%----0%
Dividend Yield
1.54%1.76%-0.95%-0.47%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
17.2930.19-40.33-46.89
Forward PE
-32.9732.9725.8915.7326.00
P/FCF Ratio
22.2633.1462.2220.5926.4323.06
PS Ratio
6.334.234.734.754.435.98